Jerry J. Buccafusco

Medical College of Georgia, Augusta, GA, United States 
Neuroscience Biology, Molecular Biology, Cell Biology
"Jerry Buccafusco"
Mean distance: 26716.5
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Webster SJ, Mruthinti S, Hill WD, et al. (2012) An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease. Neuromolecular Medicine. 14: 119-30
Terry AV, Buccafusco JJ, Schade RF, et al. (2012) The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats. Biochemical Pharmacology. 83: 941-51
Hall BJ, Pearson LS, Terry AV, et al. (2011) The use-dependent, nicotinic antagonist BTMPS reduces the adverse consequences of morphine self-administration in rats in an abstinence model of drug seeking. Neuropharmacology. 61: 798-806
Webster SJ, Wilson CA, Lee CH, et al. (2011) The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys. British Journal of Pharmacology. 164: 970-8
Terry AV, Buccafusco JJ, Gearhart DA, et al. (2011) Repeated, intermittent exposures to diisopropylfluorophosphate in rats: protracted effects on cholinergic markers, nerve growth factor-related proteins, and cognitive function. Neuroscience. 176: 237-53
Terry AV, Buccafusco JJ, Herman EJ, et al. (2011) The prototypical ranitidine analog JWS-USC-75-IX improves information processing and cognitive function in animal models. The Journal of Pharmacology and Experimental Therapeutics. 336: 751-66
Rueter LE, Rêlo AL, van Gaalen MM, et al. (2011) The use of the scopolamine-induced cognitive impairment model to translate on-target activity for ABT-894 from rodents/monkeys to humans: Preclinical evidences Biochemical Pharmacology. 82: 1043
Kohlhaas KL, Robb H, Roderwald V, et al. (2011) α7 NNR allosteric modulation in behavioral models of cognition Biochemical Pharmacology. 82: 1042
Millan MJ, Buccafusco JJ, Loiseau F, et al. (2010) The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 1035-51
Bitner RS, Bunnelle WH, Decker MW, et al. (2010) In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease. The Journal of Pharmacology and Experimental Therapeutics. 334: 875-86
See more...